[Ligand-receptor binding kinetics in drug design]

Area of Science:

• Pharmacology and Drug Discovery
• Biochemistry and Molecular Biology
• Computational Chemistry

Background:

• Traditional drug development prioritizes thermodynamic affinity over kinetic parameters.
• In vitro measurements of drug-receptor interactions differ significantly from in vivo conditions.
• Emerging evidence highlights the critical role of binding kinetics in overall drug efficacy.

Purpose of the Study:

• To explore the theoretical underpinnings of protein-ligand binding kinetics.
• To identify molecular determinants that govern the rates of drug-receptor association and dissociation.
• To emphasize the importance of kinetic parameters in preclinical drug candidate assessment.

Main Methods:

• Review of theoretical frameworks for protein-ligand interactions.
• Analysis of molecular factors influencing binding kinetics.
• Discussion of kinetic selectivity and residence time in drug action.

Main Results:

• Binding kinetics, specifically association and dissociation rate constants, significantly impact drug effectiveness.
• Long residence times can lead to kinetic selectivity and sustained pharmacological activity at lower concentrations.
• Understanding molecular determinants of binding kinetics aids in rational drug design.

Conclusions:

• Kinetic parameters of drug-receptor binding are vital for drug development, complementing traditional affinity measures.
• Characterizing binding kinetics enhances the prediction of in vivo drug performance.
• This knowledge facilitates the rational design of novel therapeutics with improved properties.